Free Access to FDA 483s
Recommendation
4/5 December 2024
Berlin, Germany
A CAPA Workshop on Successful Failure Investigation
Many people in the pharmaceutical industry are aware of the fact that Warning Letters issued by the US Food and Drug Administration (FDA) are published on the FDA website.
But the Office of Regulatory Affaires (ORA) is also publishing other copies of ORA domestic inspection and related records. This is done either proactively at ORA's discretion or because they are "frequently requested" per the Electronic Freedom of Information Act Amendments of 1996.
Here is an overview on what is available:
- 483 observations are best to be seen at the "frequently requested or proactively posted compliance records" site
- Enforcement Reports, Recalls, Import Alerts, Import Refusals etc. can be found at the data sets page
- Warning Letters are accessible on a dedicated page for Warning Letters
- Establishment Inspection Reports can be searched in the ORA FOIA Electronic Reading Room
- Persons currently debarred pursuant to sections 306(a) or (b) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 335(a) or (b) are listed in the FDA Debarment list
- Other ORA documents cab be found on the ORA home page.
Related GMP News
30.10.2024From missing Analysis to Brand Protection Violations - FDA Warning Letter to Canadian Manufacturer
23.10.2024Root Cause Analysis: What can be found in FDA Warning Letters?
23.10.2024Do you want to host FDA Staff? FDA announces Experiential Learning Site Visit Program
09.10.2024Management circumvents Quality Department in Deviation Classification - FDA Warning Letter
09.10.2024Despite MRA: Why does the FDA inspect so frequently in the EU?
02.10.2024Swissmedic launched own GMDP Database